From: Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032
Cell lines
VC(0.1 mM)
IC50(μM)
95% CI of IC50(μM)
8505C
–
17.39
13.34–22.67
+
9.21
7.50–11.31
BCPAP
4.75
3.95–5.72
2.43
1.95–3.04
8305C
7.56
5.98–9.54
3.14
2.61–3.79